YURAK-QON TOMIR KASALLIKLARI BO‘LGAN BEMORLARDA QANDLI DIABET FONIDA LIPID ALMASHINUVI BUZILISHLARINI DAVOLASH STRATEGIYALARI
Abstract
Yurak-qon tomir kasalliklari (YQTK) va qandli diabet (QD) dunyo bo‘yicha o‘lim va nogironlikning yetakchi sabablaridan biri hisoblanadi. Ushbu ikki patologiyaning birgalikda uchrashi bemorlarning holatini murakkablashtirib, davolash strategiyalariga jiddiy o‘zgartirishlar kiritishni talab etadi. Ayniqsa, lipid almashinuvi buzilishlari ateroskleroz jarayonini jadallashtirib, koronar yurak kasalliklari xavfini oshiradi. Shu sababli, QD fonida YQTK bo‘lgan bemorlarda gipolipidemik terapiyaning samaradorligi muhim ilmiy va amaliy ahamiyat kasb etadi.
Downloads
References
1. World Health Organization. Global report on diabetes. Geneva: WHO, 2021.
2. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082-e1143.
3. Mach F, Baigent C, Catapano AL, et al. ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2020;41(1):111-188.
4. American Diabetes Association. Standards of medical care in diabetes—2022. Diabetes Care. 2022;45(Suppl 1):S1-S266.



















